A mum whose "out of control" migraines were so severe they affected her speech has finally found a solution that works for ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.

Anti-CGRP antibodies vs onabotulinumtoxinA is not associated with increased cardiovascular disease risk in older patients ...

The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market.

Neurological disorders such as migraine and post-traumatic headache (PTH) not only cause significant individual suffering but also lead to substantial ...

CGRP Inhibitors Market. The global CGRP inhibitors market is poised for robust growth, with its valuation expected to rise ...